Home » Topics » Regulatory

Regulatory
RSS

Simdax approved in Sweden for severe heart failure

Sep. 28, 2000

Combinations with synergistic antitumor activity claimed by Pharmacia

Sep. 27, 2000

FDA approves Trisenox for APL only three years after U.S. studies began

Sep. 27, 2000

Levaquin tablets/injection approved for new indication in U.S.

Sep. 22, 2000

Once-daily tramadol enters phase III

Sep. 21, 2000

FDA approves QVAR Inhalation Aerosol for treatment of asthma

Sep. 20, 2000

New formulation of Zyprexa introduced for psychotic disorders and manic episodes

Sep. 20, 2000

Glaxo Wellcome seeks new indication for Relenza

Sep. 19, 2000

New HIV treatment option approved by FDA

Sep. 19, 2000

New therapy for AIDS wasting receives orphan product designation from E.C.

Sep. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...